- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
Lyell Immunopharma (NASDAQ:LYEL), Quotes and News Summary
Lyell Immunopharma (NASDAQ: LYEL)
Earnings
see more| Q2 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.040 | ||||||
| REV | 35.741M |
| Q1 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.200 | ||||||
| REV | 553.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
Lyell Immunopharma Questions & Answers
You can purchase shares of Lyell Immunopharma (NASDAQ: LYEL) through any online brokerage.
Other companies in Lyell Immunopharma’s space includes: Zentalis Pharmaceuticals (NASDAQ:ZNTL), Sage Therapeutics (NASDAQ:SAGE), Day One Biopharmaceutical (NASDAQ:DAWN), Xencor (NASDAQ:XNCR) and SpringWorks Therapeutics (NASDAQ:SWTX).
The latest price target for Lyell Immunopharma (NASDAQ: LYEL) was reported by Goldman Sachs on Tuesday, May 24, 2022. The analyst firm set a price target for 12.00 expecting LYEL to rise to within 12 months (a possible 58.73% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Lyell Immunopharma (NASDAQ: LYEL) is $7.56 last updated Today at August 9, 2022, 7:35 PM UTC.
There are no upcoming dividends for Lyell Immunopharma.
Lyell Immunopharma’s Q2 earnings are confirmed for Thursday, August 4, 2022.
There is no upcoming split for Lyell Immunopharma.
Lyell Immunopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.